Clinical Trial Update: Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update examines the combination of epirubicin, carboplatin, and capecitabine in patients with unresectable locally advanced, metastatic, or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Extrahepatic Cholangiocarcinoma
• Gastric Cancer
• Head and Neck Cancer
• Hepatocellular Carcinoma
• Unspecified Adult Solid Tumor

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Capecitabine (capecitabine)
• Epirubicin (epirubicin)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Esophageal Cancer, Extrahepatic Bile Duct Cancer | Phase 1, Phase 2 | Status: COMPLETED